NY-ESO-1 TCR-T cells

· TCRCure Biopharma Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NY-ESO-1 TCR-T cells, covering 2025-07-16 to 2025-07-16. Get the full timeline:

Most recent: Clinical Trial Update: NY-ESO-1 TCR-T Cells for NY-ESO-1 Positive Subjects With Advanced Solid Tumors [Phase 1]